جست‌وجوی استاد و پژوهشگر

Odd Olai Aalenمشاهده پروفایل

استاد

• Biostatistics
• Survival Analysis
• Causal Inference
• +۳ مورد دیگر

Odd Olai Aalen is a Professor of Medical Statistics at the University of Oslo, holding a PhD in Biostatistics from UC Berkeley. His research focuses on survival analysis, causal inference, and epidemiological modeling, contributing to advancements in statistical methodologies for clinical and public health applications. Aalen has been recognized for his work, including presenting the 2010 Armitage Lecture in Cambridge. Education: PhD in Biostatistics, UC Berkeley Research Interests: Development and application of survival analysis techniques Causal inference in medical research Frailty modeling in epidemiology Methodological innovations in longitudinal data analysis Recent Publications Trends: Aalen's work emphasizes translating statistical theory into practical tools for understanding disease mechanisms and treatment effects. His articles frequently address challenges in clinical trial design, mediation analysis, and addressing biases in observational studies. Key themes include improving outcomes prediction, refining causal pathway models, and integrating longitudinal data with survival analysis. Awards: 2010 Armitage Lecture, University of Cambridge Advising & Grants: While specific grant details are not listed, his extensive publication record reflects sustained funding in biostatistics and medical research. He leads the Causal inference and event history analysis research group, fostering interdisciplinary collaboration. Labs/Teams: Active in the Causal inference and event history analysis group at the University of Oslo, focusing on statistical methodologies for medical and epidemiological challenges.

Niklas Björkströmمشاهده پروفایل

استاد

• Immunology
• Infectious Medicine
• Cancer Immunology
• +۴ مورد دیگر

Niklas Björkström is a Professor/Specialist Physician at Karolinska Institutet (KI) in Sweden, affiliated with the Department of Medicine, Huddinge. He leads the Human tissue-resident NK cells research group and is based at the Center for Infectious Medicine (CIM). His dual role combines academic leadership with clinical work at Karolinska University Hospital's Clinical Microbiology department. Education: Björkström earned his MD (2010) and PhD (2011) in Immunology from KI. He completed postdoctoral training at the National Institutes of Health (NIH), USA, before returning to KI as a Principal Investigator in 2014 and becoming a Professor in 2023. He holds an Associate Professor title (2016). Research Interests: His laboratory focuses on understanding human tissue-resident lymphocytes, particularly natural killer (NK) cells, in the liver, uterus, and other organs. Key areas include NK cell biology in liver diseases (e.g., PSC, NASH, hepatitis viruses) and pregnancy immunology. Techniques used include high-dimensional flow cytometry, CyTOF, microscopy, and computational tools (e.g., SPADE, SNE). The group collaborates with Hannover Medical School and the International PSC Study Group. Awards: Björkström has received prestigious honors such as the ERC Starting Grant (2020), Anders Jahre Award (2020), and NovoNordisk Foundation Emerging Investigator (2021). He is also a Wallenberg Academy Fellow (2017–2021). Grants & Advising: He oversees grants like the Swedish Cancer Foundation (2021–2023) and Karolinska Institutet's KID and Assistant Professor Tenure Track grants. Advised students include Christine Zimmer (PhD), Lena Berglin, and others now in postdoc roles or industry positions. Labs & Teams: The Björkström group is part of KI's Department of Medicine, Huddinge, and maintains close ties with clinical units at Karolinska University Hospital. They have open postdoctoral positions and collaborate internationally on liver and pregnancy immunology projects.

Alfredo Mayorمشاهده پروفایل

استاد پژوهشی

• Malaria
• Neglected Parasitic Diseases

Alfredo Mayor is a Research Professor at the Barcelona Institute for Global Health (ISGlobal), specializing in Malaria and neglected parasitic diseases. His research employs a discovery-oriented approach focused on Mozambique, combining genomic tools, epidemiological methods, and clinical trials to develop malaria surveillance strategies. Core principles include advancing scientific knowledge, prioritizing programmatic needs through National Malaria Control Program collaborations, translational host-parasite biology research, and capacity building in endemic regions. Research focuses on: Cost-effective malaria stratification for interventions Intervention efficacy assessment Early parasite threat detection Transmission reservoir targeting National surveillance capacity expansion His publications demonstrate consistent focus on genomic surveillance, molecular diagnostics, and epidemiological modeling of malaria in Mozambique. Articles frequently address the intersection of malaria with other infectious diseases like HIV and COVID-19, emphasizing public health applications in resource-limited settings.

• Biophysics
• Molecular Dynamics Simulations
• Membrane Biology
• +۴ مورد دیگر

Balázs Fábián is a postdoctoral researcher at the Max Planck Institute of Biophysics in the group of Gerhard Hummer. He holds a PhD from the University Bourgogne Franche-Comté (France) and Budapest University of Technology and Economics (Hungary). His research focuses on molecular dynamics simulations of lipid membranes and viral systems, particularly studying viral budding mechanisms in enveloped viruses like HIV. Fábián’s work bridges computational biophysics and membrane biology, with applications ranging from anaesthesia mechanisms to neurodegenerative diseases. Education: BSc and MSc in Chemical Engineering from Debrecen and Budapest Universities (Hungary), followed by a PhD in Biophysics. Previously, he conducted postdoctoral research at the Czech Academy of Sciences and the Max Planck Institute. Research Interests: Computational modeling of lipid bilayers, viral membrane interactions, anaesthetic effects on membranes, and protein aggregation in neurodegenerative contexts. His methods include molecular dynamics simulations and coarse-grained modeling (e.g., Martini force field). Teaching and Mentorship: Guides junior researchers in computational techniques and simulation methodologies. Active in conference presentations and publication preparation. Future Goals: Aims to lead a junior research group via the Emmy Noether program, focusing on advancing computational tools for membrane systems and viral dynamics.

• Implementation Science
• Mental Health
• Person-Centered Care
• +۷ مورد دیگر

Mimi Choy-Brown is an Associate Professor in the School of Social Work at the University of Minnesota, Twin Cities. Her work centers on implementation science, mental health services research, clinical supervision, and organizational strategies to reduce health disparities. She is actively involved in multiple NIH- and SAMHSA-funded research projects addressing HIV stigma, telehealth access for marginalized populations, and workforce retention in mental health care. University: University of Minnesota School: School of Social Work Department: Social Work Rank: Associate Professor Her research interests focus on improving mental health equity through systemic interventions. Key areas include implementation science , person-centered care , clinical supervision , organizational culture , and healthcare access for vulnerable populations such as refugees, immigrants, and people who inject drugs. She applies mixed methods and implementation frameworks to evaluate and enhance service delivery models. The most recent articles (2019–2025) reflect a strong trajectory in implementation science and mental health policy. Common themes include workforce retention, fidelity monitoring, trauma-informed care, and digital health tools like clinical decision support systems. Her work often involves collaborative, interdisciplinary teams and real-world settings such as primary care clinics, syringe service programs, and child welfare agencies. Scientific contributions include: Development of multilevel frameworks for implementation trials Strategies for reducing HIV stigma using standardized patients Integration of telehealth in harm reduction settings Organizational investments to promote mental health equality She has served as Principal Investigator and Co-Investigator on multiple federally funded grants, demonstrating leadership in securing external funding. These projects emphasize community engagement, resilience-building for refugee and immigrant youth, and scalable models for mental health service delivery. Although student advisees are not listed, her supervisory focus in research suggests mentorship in clinical and organizational research methods. She leads the LIFT Project for Northwest MHTTC and contributes to national initiatives aimed at improving mental health systems. Dr. Choy-Brown is actively engaged in research teams and collaborative networks focused on implementation science, mental health equity, and public health innovation. Her work spans academic, clinical, and community-based settings, emphasizing practical solutions to systemic challenges in mental health care.

Peter Verwilstمشاهده پروفایل

دانشیار

• Medicinal Chemistry
• Allosteric Modulation of Enzyme Targets
• Fluorescent Markers for Neurodegenerative Diseases
• +۵ مورد دیگر

Peter Verwilst is an Associate Professor at the Medicinal Chemistry division of the Rega Institute for Medical Research , part of KU Leuven 's Department of Pharmaceutical and Pharmacological Sciences. He leads projects in allosteric modulation of enzyme targets , fluorescent markers for neurodegenerative diseases , and novel antimicrobial development , particularly focusing on Gram-negative bacteria and HIV-related therapies. His research integrates computational modeling , chemical synthesis , and fluorescent probe design . He supervises PhD students including Margaux Billen , Eline Goffin , and Radu Bulai , and collaborates with institutions like Masaryk University and the Institut Pasteur de Lille. Current projects explore CCR5 signaling modulators , PurK inhibitors , and DNA-Encoded Libraries for P. aeruginosa antibiotics. Scientific awards include supporting students like Radu Bulai in obtaining FWO PhD Fellowships . His teaching includes Organische chemie I & II and Medicinale chemie courses. The lab recently celebrated securing a C1 grant and welcomes international collaborations.

• Epidemiology
• HIV
• Sexually Transmitted Infections
• +۴ مورد دیگر

Lei Zhang is a Professor (Research) and Head of the Artificial Intelligence and Modelling in Epidemiology Program at the School of Translational Medicine, Monash University, Australia. He holds adjunct roles at institutions like Tsinghua University and is a consultant to the WHO Western Pacific Region. His expertise spans HIV/STI epidemiology, mathematical modelling, and AI-driven healthcare solutions. Education: Bachelor of Advanced Science in Mathematics (University of Sydney, 2001) Master of Science in Applied Mathematics (University of Sydney, 2003) PhD in Medicine (UNSW, 2006) Master of Public Health (Hamburg University of Applied Sciences, 2009) Research Interests: Prof. Zhang focuses on cross-disciplinary research in HIV/STI epidemiology, AI applications for disease modeling and diagnostics, health economics, and global health policy. His work integrates mathematical models with clinical data to optimize interventions and inform policy. Key Projects: HOPE: Optimizing HIV Pre-Exposure Prophylaxis (PrEP) in East Asia WHO Collaborations: Supporting global STI programs and policy development China-Australia Joint Research Center for Infectious Diseases Awards: 2021 ASRHA Innovation Award for HIV/STI research contributions Advising & Grants: Supervised 21 students (6 PhD, 15 MSc) and currently co-supervises 24 students (11 PhD, 13 MSc). Leader of 5+ major research grants, including NHMRC-funded projects on STI control and diabetes research. Labs/Teams: Leads the AI & Modelling in Epidemiology Program and collaborates with global networks like UNAIDS, the World Bank, and ministries of health across the Western Pacific region.

• Implementation science
• HIV
• Hypertension
• +۵ مورد دیگر

Dr. Matthew Hickey is an Assistant Professor of Medicine in the Division of HIV, ID, & Global Medicine at the University of California, San Francisco (UCSF) School of Medicine. He serves as a primary care physician and research lead for the POP-UP clinic, a low-barrier HIV care program for people experiencing homelessness in San Francisco. Dr. Hickey also holds editorial positions as Implementation Science Section Editor for Current HIV/AIDS Reports and Associate Editor for Implementation Science Communications. Dr. Hickey's educational background includes: Master of Advanced Studies (MAS) in Clinical Research, Implementation Science from UCSF (2024) Fellowship in HIV Medicine from UCSF (2022) Chief Residency in Internal Medicine from UCSF (2019) Residency in Internal Medicine, San Francisco General Primary Care Track from UCSF (2018) MD from UCSF (2015) BS in Biochemistry from Texas A&M University (2009) Dr. Hickey's research focuses on implementation strategies to improve delivery of hypertension and cardiovascular disease prevention in rural East Africa, and on developing low-barrier models of HIV care for people experiencing homelessness in urban U.S. settings. His work spans implementation science, HIV care, hypertension management, and community health worker programs. He examines differentiated service delivery models for patients with barriers to usual care engagement, particularly those experiencing homelessness or living in resource-limited settings. His research integrates clinical care with innovative implementation approaches to address health disparities in both domestic and global contexts. Dr. Hickey's recent publications demonstrate a strong focus on implementation science approaches to address HIV care and comorbid conditions. His work spans both domestic settings (particularly San Francisco) and international contexts (Kenya and Uganda). A significant theme across his publications is the development and evaluation of innovative care models for vulnerable populations, including people experiencing homelessness and those in resource-limited settings. His research frequently examines the integration of services (particularly HIV and hypertension care), the use of community health workers, and novel approaches to medication delivery including long-acting injectables and polypills. Dr. Hickey has received numerous awards and honors: Alpha Omega Alpha Honor Medical Society (2014) UCSF Deans Prize for Outstanding Medical Student Research & Scholarship (2015) NIH LRP Award from the National Institute of Allergy & Infectious Disease (2020) CROI Young Investigator Award (2020) Early Career Award for Excellence in Clinical Research from UCSF-Gladstone Center for AIDS Research (2021) Clinical Fellowship Program award from the AIDS Research Institute (2021) CROI Young Investigator Award (2022) Dr. Hickey is actively involved in research funding and mentorship. He serves as Principal Investigator on multiple grants including an NIH K23 award focused on hypertension treatment in Kenya, a Benioff Homelessness and Housing Initiative grant developing mobile outreach for people experiencing homelessness who have fallen out of HIV care, and NIH-funded research on weight gain and metabolic effects following antiretroviral therapy changes in Western Kenya. He is available to mentor UCSF students, residents, and fellows on research projects and is affiliated with the UCSF Institute for Global Health Sciences. His work with the POP-UP clinic represents a significant contribution to low-barrier HIV care models for vulnerable populations. Dr. Hickey's research is closely tied to the POP-UP clinic program in San Francisco and various research initiatives in Kenya and Uganda. His work with community health workers in East Africa represents a significant team-based approach to addressing hypertension and HIV care in resource-limited settings. These international collaborations involve multiple institutions in Kenya and Uganda, creating a robust research network focused on implementation science in global health contexts.

• Infectious Diseases
• HIV/AIDS Research
• Antimicrobial Resistance
• +۵ مورد دیگر

Dr. Steven Aronin is an Associate Clinical Professor of Medicine at Yale School of Medicine and serves as Chief of Infectious Disease at Waterbury Hospital. He holds multiple leadership roles including Medical Director of the Waterbury Hospital Infectious Disease and Travel Clinic, Program Director for Ryan White HIV Programs, and Hospital Epidemiologist. His academic work focuses on infectious diseases, particularly meningitis, endocarditis, HIV/AIDS, and antibiotic efficacy. Dr. Aronin completed his MD at Ross University School of Medicine and residency at Yale Primary Care Internal Medicine Program. He has been a Core Faculty member at Waterbury Hospital since 2009 and oversees the Yale-Waterbury Internal Medicine Residency Program's Infectious Disease training. He is also President of the Connecticut Infectious Disease Society. His research emphasizes translational antibiotic studies, particularly sulopenem's efficacy against resistant pathogens like E. coli and K. pneumoniae. Recent work includes phase 3 trials comparing sulopenem to ertapenem for intra-abdominal infections, and evaluating its use in UTIs and anthrax models. Key findings include sulopenem's superior efficacy in UTIs and its potential as a biodefense agent against inhalational anthrax. Dr. Aronin actively contributes to clinical guidelines through studies on HIV screening integration and bacteriuria's clinical impact. His work bridges academic research with direct patient care, emphasizing antibiotic stewardship and improving infectious disease treatment outcomes.

• Emergency Medicine
• Medical Toxicology
• Drug Overdose
• +۴ مورد دیگر

Alex F. Manini, MD, MS, is a Professor of Emergency Medicine at the Icahn School of Medicine at Mount Sinai, where he practices clinically at Elmhurst Hospital Center in New York City. He serves as the Director of the Mount Sinai Center for Research on Emerging Substances, Poisoning, Overdose, and New Discoveries (RESPOND Center), and the Associate Program Director of the T32 Clinician Scientist Training Program focused on emergency care research. Dr. Manini earned his Bachelor of Science from MIT, Doctor of Medicine from UCSF School of Medicine, completed his Emergency Medicine Residency at Harvard Affiliated Emergency Medicine Residency (Brigham & Women's Hospital / Massachusetts General Hospital), and Medical Toxicology Fellowship at NYU/Bellevue where he also earned a Master of Science in Clinical Investigation. Dr. Manini's research focuses on emergency medicine and medical toxicology, with particular expertise in drug overdose, opioid-related emergencies, cardiovascular complications of drug overdose, and novel substances of abuse. His work aims to develop clinical tools to individualize prevention strategies for curtailing the national rise in drug overdose fatalities through risk prediction instruments, laboratory biomarkers, and genetic analyses. He has published over 110 peer-reviewed articles in the emergency medicine and medical toxicology literature. Analysis of Dr. Manini's recent publications reveals a strong focus on emerging drug threats, particularly novel synthetic opioids like nitazenes and fentanyl analogs, as well as the increasing prevalence of xylazine and other adulterants in the illicit drug supply. His research spans emergency department management protocols, health disparities in overdose treatment, and the intersection of mental health and substance use disorders. Scientific Awards: Fellow of the American College of Medical Toxicology (FACMT) Young Investigator of the Year, Society of Academic Emergency Medicine (SAEM) NIH Study Section Member, CEBRA (Cutting Edge Basic Research Awards) NIH Early Career Reviewer (ECR), Center for Scientific Review Young Investigator Award WINNER, XXXIII International Congress EAPCCT The Dr. Harold and Golden Lamport Research Award, Mount Sinai School of Medicine Dr. Manini has been continuously funded by the National Institutes of Health (NIH) since 2009, totaling over $10 million as a principal investigator. He has mentored over 40 pre- and post-doctoral students, residents, and junior faculty who have secured millions in federal grant funding. His major grants include an R01 from NIDA studying risk prediction for overdose fatalities, an R56 as Site PI for the NIDA National Early Warning System Network (iN3), and a K23 Career Development Award. As Director of the RESPOND Center (Research on Emerging Substances, Poisoning, Overdose, and New Discoveries), Dr. Manini leads a multidisciplinary team focused on identifying emerging drug threats and developing evidence-based approaches to manage novel substances of abuse. His work bridges emergency medicine, toxicology, cardiology, and public health to address the evolving overdose epidemic.

Stefan Baralمشاهده پروفایل

استاد

• Epidemiology
• Implementation Research
• Infectious Disease Epidemiology
• +۱۴ مورد دیگر

Stefan Baral is a Professor in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health, with affiliations in the Center for Global Health and the Center for Public Health and Human Rights. He is the co-director of the Program for Implementation and Equity Research (PIER) and leads multiple NIH-funded initiatives focused on HIV, stigma, and implementation science. Education: MD, Queen’s University (2005) MSc, McMaster University (2001) MPH, Johns Hopkins Bloomberg School of Public Health (2007) MBA, Johns Hopkins Carey Business School (2007) His research focuses on epidemiology and implementation science related to infectious diseases, particularly HIV and STIs among key populations such as men who have sex with men, female sex workers, and transgender individuals. He investigates stigma, mental health, and structural barriers to care in Sub-Saharan Africa and the U.S. His work emphasizes equity, human rights, and scalable public health interventions. His extensive publication record, with over 550 outputs, demonstrates consistent leadership in HIV epidemiology, stigma measurement, and implementation research. Recent articles highlight his focus on big data, PrEP access, gender-based violence in conflict settings, and community-engaged implementation science. Scientific Awards: Research Contributions to Health in Senegal, Ministry of Health, Senegal (2018) Global Health Advising Award, Johns Hopkins (2015, 2012) C.P. Shah Award for Resident Research (2009) Multiple scholarships and recognitions from 2000–2008 Baral is actively involved in advising and grant leadership, serving as Principal Investigator on multiple R01 grants from NIH, amFAR, and the Global Fund. He co-directs the Implementation Science concentration in the DrPH program and teaches advanced courses in implementation research methods. He leads collaborative teams across global institutions and community organizations, emphasizing equity and impact in public health science. He is affiliated with key research hubs including the Center for AIDS Research (CFAR) Implementation Science core and the Mid-Atlantic Consortium (MACC+) Implementation Science support hub.

Thomas Cokelaerمشاهده پروفایل

پژوهشگر

• Bioinformatics
• Data Analysis
• Machine Learning
• +۱۲ مورد دیگر

Thomas Cokelaer is a researcher at the Institut Pasteur, affiliated with the Bioinformatics and Biostatistics HUB and based at the Platform Biomics. Since October 2018, he has led the SALSA (dry-lab) group, focusing on bioinformatics software development and data analysis. His interdisciplinary background spans astronomy, plant modeling, systems biology, and drug discovery. Institution: Institut Pasteur Unit: Bioinformatics and Biostatistics HUB Platform: Platform Biomics Group: SALSA (dry-lab group) leader His research interests center on bioinformatics, next-generation sequencing (NGS) analysis, machine learning, data visualization, and reproducible research. He develops and maintains several widely used open-source tools including Sequana (NGS pipelines), BioServices (biological web services), Bioconvert (format conversion), Sequanix (GUI for Snakemake), and GDSCTools (pharmacogenomics). He is deeply committed to promoting reproducibility in computational research through initiatives like reprohackathons. The recent publications reflect a strong trend in computational biology, with a focus on developing bioinformatics methodologies, improving data analysis workflows, and applying these tools to diverse biological problems such as fungal pathogenesis, cancer pharmacogenomics, mitochondrial metabolism, and viral evolution. The work spans genomics, transcriptomics, systems biology, and software engineering. He has contributed to numerous scientific software projects as Principal Investigator, including Sequana, Bioconvert, GDSCTools, DREAMTools, and Sequanix. He has also taught courses in scientific programming with Python and reproducible data analysis at the Institut Pasteur. His collaborative network includes researchers from EMBL-EBI, Sanger Institute, INRIA, and international partners within the Pasteur Network. The SALSA group hosts master’s students and visiting researchers annually.

Jason Besteمشاهده پروفایل

دانشیار

• Infectious Diseases
• Public Health
• Global Health Systems
• +۴ مورد دیگر

Dr. Jason Beste, MD, MPH, is an Associate Professor in the Department of Clinical Research and Public Health at Creighton University School of Medicine. He serves as Executive Director of the Arrupe Global Scholars and Partnerships Program, focusing on health systems strengthening in post-conflict settings. A dual graduate of Creighton University (undergraduate and medical degree), he completed residency training at Albert Einstein School of Medicine/Montefiore Medical Center and an Infectious Disease fellowship with an MPH at the University of Washington. Education Creighton University: Undergraduate Degree Creighton University School of Medicine: MD University of Washington: MPH, Infectious Disease Fellowship Albert Einstein School of Medicine: Internal Medicine Residency Dr. Beste specializes in health systems strengthening in post-conflict environments, with extensive experience in Liberia, Malawi, and Mozambique. His work addresses health equity, infectious disease management, and primary care delivery in resource-limited settings. He previously held faculty appointments at Harvard Medical School and the University of Washington, where he contributed to global health education and research. His research spans HIV/TB diagnostics , post-Ebola recovery , and structural drivers of health disparities . Recent publications analyze mental health screening tools in Liberia, HIV care models in Malawi, and ART scale-up strategies in Ukraine. Dr. Beste co-chaired the Liberia NCDI Poverty Commission Report, advocating for non-communicable disease integration in post-conflict health systems. Currently, he leads global health initiatives through Creighton University's Arrupe Global Scholars program, fostering partnerships to improve healthcare access in underserved regions.

Rebekah Israel Crossمشاهده پروفایل

استادیار

• Structural Inequality and Health
• Racism and Public Health
• Housing Discrimination and Health Outcomes
• +۷ مورد دیگر

Rebekah Israel Cross is an Assistant Professor at the University of Chicago's Department of Public Health Sciences . Her work lies at the intersection of structural inequality , racism , and health outcomes with particular focus on housing discrimination , residential segregation , and maternal health disparities . Prior to her current position, she completed a postdoctoral fellowship at UNC Gillings School of Global Public Health and earned her PhD in Community Health Sciences from UCLA with a minor in Urban Planning . Her research agenda combines Critical Race Theory with quantitative and qualitative methodologies to analyze how systemic racism shapes population health. She has developed innovative frameworks for measuring racism's impact through housing policy and medical tools while exposing how racialized systems perpetuate health inequities. Her teaching philosophy emphasizes co-learning , student well-being , and anti-bias practices , with particular attention to ungrading and radical pedagogy . Rebekah's recent publications focus on causal relationships between gentrification and preterm birth among Black populations, while her methodological work challenges the biological fallacy of race in medical calculators like VBAC prediction tools. She has received multiple fellowships including the Health Policy Research Scholars Award and Robert Wood Johnson Foundation support . Her advocacy extends beyond academia through public writing about Black maternal health , Palestinian solidarity , and personal resilience .

Rubee Devمشاهده پروفایل

استادیار

• Sex and Gender in Health
• Cardiovascular Disease
• Global Health
• +۴ مورد دیگر

Rubee Dev is an Assistant Professor and VSP Faculty Coordinator at the School of Nursing within the Faculty of Applied Science, University of British Columbia. Her office is located in T153 Koerner Pavilion at 2211 Wesbrook Mall, Vancouver, BC, Canada, with contact phone 604.822.6249 and email rubee.dev@ubc.ca. Her educational background includes a Master of Public Health (MPH) and Doctor of Philosophy (PhD). These qualifications underpin her expertise in epidemiological methods and public health interventions. Dr. Dev's research centers on sex and gender as critical determinants of health outcomes, with particular focus on cardiovascular disease, global health disparities, and public health systems. She investigates how biological sex and sociocultural gender factors influence disease progression, treatment adherence, and health behaviors across diverse populations. Her work bridges clinical practice and population health through rigorous mixed-methods approaches including cohort studies, systematic reviews, and predictive modeling. Analysis of her recent publications reveals consistent emphasis on sex and gender frameworks across cardiovascular health in South Asia and Sub-Saharan Africa, mental health during the pandemic in Europe, and maternal-child health in Nepal. She has pioneered tools like the CR-DECIDE models for shared decision-making in coronary artery disease, demonstrating translational impact from research to clinical practice. Her global perspective spans WHO surveillance data, national surveys, and community-based interventions in resource-limited settings. No scientific awards were documented in the provided source material. While specific advising roles and grant funding details were not disclosed, her VSP Faculty Coordinator position indicates leadership in academic program development and student mentorship at UBC. The absence of explicit grant mentions suggests potential involvement in institutionally supported initiatives or collaborative projects not detailed in the profile. Research infrastructure details including laboratories or dedicated teams were not specified in the available information, though her global collaborations imply networked research partnerships across multiple continents.